IL326819A - מעכבי גורם משלים b ושימושיהם - Google Patents
מעכבי גורם משלים b ושימושיהםInfo
- Publication number
- IL326819A IL326819A IL326819A IL32681926A IL326819A IL 326819 A IL326819 A IL 326819A IL 326819 A IL326819 A IL 326819A IL 32681926 A IL32681926 A IL 32681926A IL 326819 A IL326819 A IL 326819A
- Authority
- IL
- Israel
- Prior art keywords
- inhibitors
- complement factor
- complement
- factor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202363586620P | 2023-09-29 | 2023-09-29 | |
| PCT/IB2024/059431 WO2025068951A1 (en) | 2023-09-29 | 2024-09-26 | Complement factor b inhibitors and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL326819A true IL326819A (he) | 2026-04-01 |
Family
ID=93284092
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL326819A IL326819A (he) | 2023-09-29 | 2024-09-26 | מעכבי גורם משלים b ושימושיהם |
Country Status (6)
| Country | Link |
|---|---|
| CN (1) | CN121925409A (he) |
| AR (1) | AR133953A1 (he) |
| AU (1) | AU2024351332A1 (he) |
| IL (1) | IL326819A (he) |
| TW (1) | TW202515541A (he) |
| WO (1) | WO2025068951A1 (he) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2026008072A1 (zh) * | 2024-07-05 | 2026-01-08 | 南京正大天晴制药有限公司 | 补体因子b抑制剂在制备治疗或预防pnh药物中的用途 |
| WO2026008074A1 (zh) * | 2024-07-05 | 2026-01-08 | 南京正大天晴制药有限公司 | 补体因子b抑制剂的晶型、其制备方法及用途 |
| WO2026008073A1 (zh) * | 2024-07-05 | 2026-01-08 | 南京正大天晴制药有限公司 | 补体因子b抑制剂的剂量组合物 |
| WO2026069246A1 (en) * | 2024-09-30 | 2026-04-02 | Novartis Ag | Complement factor b inhibitors and uses thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004078163A2 (en) | 2003-02-28 | 2004-09-16 | Transform Pharmaceuticals, Inc. | Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen |
| JO3425B1 (ar) | 2013-07-15 | 2019-10-20 | Novartis Ag | مشتقات البابيريدينيل-اندول واستخدامها كعامل متمم لمثبطات b |
| EP4650351A1 (en) * | 2023-01-09 | 2025-11-19 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Inhibitor of complement factor b |
-
2024
- 2024-09-26 CN CN202480062512.2A patent/CN121925409A/zh active Pending
- 2024-09-26 IL IL326819A patent/IL326819A/he unknown
- 2024-09-26 AU AU2024351332A patent/AU2024351332A1/en active Pending
- 2024-09-26 TW TW113136616A patent/TW202515541A/zh unknown
- 2024-09-26 AR ARP240102601A patent/AR133953A1/es unknown
- 2024-09-26 WO PCT/IB2024/059431 patent/WO2025068951A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2025068951A1 (en) | 2025-04-03 |
| AR133953A1 (es) | 2025-11-19 |
| TW202515541A (zh) | 2025-04-16 |
| AU2024351332A1 (en) | 2026-03-05 |
| CN121925409A (zh) | 2026-04-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL326819A (he) | מעכבי גורם משלים b ושימושיהם | |
| IL288381A (he) | מעכבי tead ושימושים בהם | |
| IL288384A (he) | מעכבי tead ושימושים בהם | |
| PL4031547T3 (pl) | Inhibitory kalikreiny osoczowej i ich zastosowania | |
| IL307187A (he) | מעכבי mk2 ושימושיהם | |
| EP4469449A4 (en) | PARP1 INHIBITORS AND THEIR USES | |
| IL321623A (he) | הטרוציקלים ושימושים בהם | |
| IL326350A (he) | בנזופירידינונים ובנזופירימידינונים כמעכבי pi3k | |
| IL320829A (he) | מעכבי parp1 והשימושים בהם | |
| IL300107A (he) | מעכבי hsd17b13 קווינאזולינון ושימושים בהם | |
| IL285595A (he) | מעכבים של spt5 ושימוש בהם | |
| IL296586B1 (he) | מעכבי ציקלופילין ושימושים שלהם | |
| IL314240A (he) | תרכובות ושיטות לעיכוב גורם משלים ב' | |
| IL314049A (he) | מעכבי parp7 | |
| IL292198A (he) | מעכבים של tim-3 ושימושים שלהם | |
| PL4337673T3 (pl) | Inhibitory psd-95 i ich zastosowania | |
| GB202214644D0 (en) | Sars-cov-2 mpro inhibitors and uses thereof | |
| IL316768A (he) | מעכבי mek ושימושים בהם | |
| IL310209A (he) | מעכבי rock2 ושימושים שלהם | |
| IL311588A (he) | מעכבי lpxc ושימושים בהם | |
| IL319049A (he) | מעכבי tyk2 ושימושים בהם | |
| IL314164A (he) | מעכבים של גורמים משלימים ושימושים בהם | |
| IL321740A (he) | מעכבי אינטגרין אלפא-v-בתא-8 ושימושים בהם | |
| EP4330228A4 (en) | G-ALPHA-S INHIBITORS AND USES THEREOF | |
| CA3306478A1 (en) | Complement factor b inhibitors and uses thereof |